Theraheart Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $20M

  • Investors
  • 2

Theraheart General Information

Description

Developer of implantable cardiac medical devices designed to assist patients with advanced heart failure. The company offers minimally invasive support systems with wireless energy transfer and remote monitoring, enabling hospitals and cardiac care providers to deliver long-term circulatory assistance and improve outcomes for patients with severe heart conditions.

Contact Information

Website
www.theraheart.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 16 Technology Drive
  • Suite 202
  • Irvine, CA 92618
  • United States
+1 (614)
Primary Industry
Medical Supplies
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, HealthTech
Corporate Office
  • 16 Technology Drive
  • Suite 202
  • Irvine, CA 92618
  • United States
+1 (614)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theraheart Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 29-Sep-2025 $20M Completed Startup
1. Seed Round Completed
To view Theraheart’s complete valuation and funding history, request access »

Theraheart Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-3
Series A-2
Series A-1
Seed-1 925,926 $0.000100 $1.62 $1.62 1x $1.62 5.48%
Seed 1,851,852 $0.000100 $0.81 $0.81 1x $0.81 10.96%
To view Theraheart’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Theraheart Patents

  • 29

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

Theraheart Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12708438-B2 Shunting catheters and methods for tissual removal Active 27-Sep-2024
US-20260090834-A1 Shunting catheters and methods for tissual removal Active 27-Sep-2024
WO-2026072044-A1 Shunting catheters and methods for tissual removal Pending 27-Sep-2024
US-12648811-B2 Puncture elements for shunting catheters Active 09-Jul-2024
US-20260013933-A1 Puncture elements for shunting catheters Active 09-Jul-2024 A61B18/1492
To view Theraheart’s complete patent history, request access »

Theraheart Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Theraheart Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Qiming Venture Partners Venture Capital Minority
SunMed Capital Venture Capital Minority
To view Theraheart’s complete investors history, request access »

Ready to get started?

Request a free trial

Theraheart FAQs

  • When was Theraheart founded?

    Theraheart was founded in 2023.

  • Where is Theraheart headquartered?

    Theraheart is headquartered in Irvine, CA.

  • What is the size of Theraheart?

    Theraheart has 5 total employees.

  • What industry is Theraheart in?

    Theraheart’s primary industry is Medical Supplies.

  • Is Theraheart a private or public company?

    Theraheart is a Private company.

  • What is the current valuation of Theraheart?

    The current valuation of Theraheart is .

  • What is Theraheart’s current revenue?

    The current revenue for Theraheart is .

  • How much funding has Theraheart raised over time?

    Theraheart has raised $23M.

  • Who are Theraheart’s investors?

    Qiming Venture Partners and SunMed Capital have invested in Theraheart.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process